Global Candidiasis Therapeutics Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Candidiasis Therapeutics market size was estimated at USD 3202.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Candidiasis Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Candidiasis Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Candidiasis Therapeutics market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Candidiasis Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Candidiasis Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Candidiasis Therapeutics market size was estimated at USD 3202.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Candidiasis Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Candidiasis Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Candidiasis Therapeutics market.
Global Candidiasis Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Novartis AG
- Amgen
- F. Hoffmann-La Roche Ltd.
- Bayer-Algeta
- Merrion Pharmaceuticals Plc.
- Ablynx
- Genta Incorporated
- Galapagos NV
- Catena Pharmaceuticals Inc.
- Digna Biotech S.L.
- Medivir AB
- Amura Holdings
Market Segmentation (by Type)
- Doxorubicin
- Cisplatin
- 7Carboplatin
- Etoposide
- Ifosfamide
- Cyclophosphamide
- Methotrexate
- Vincristine
Market Segmentation (by Application)
- Multispecialty Hospitals
- Cancer Research Institutes
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Candidiasis Therapeutics Market
Overview of the regional outlook of the Candidiasis Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Candidiasis Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Candidiasis Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Candidiasis Therapeutics
1.2 Key Market Segments
1.2.1 Candidiasis Therapeutics Segment by Type
1.2.2 Candidiasis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANDIDIASIS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Candidiasis Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Candidiasis Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANDIDIASIS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Candidiasis Therapeutics Product Life Cycle
3.3 Global Candidiasis Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Candidiasis Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Candidiasis Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Candidiasis Therapeutics Market Competitive Situation and Trends
3.8.1 Candidiasis Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Candidiasis Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANDIDIASIS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Candidiasis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANDIDIASIS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Candidiasis Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Candidiasis Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Candidiasis Therapeutics Market Size by Type (2020-2025)
6.4 Global Candidiasis Therapeutics Price by Type (2020-2025)
7 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Candidiasis Therapeutics Market Sales by Application (2020-2025)
7.3 Global Candidiasis Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
8 CANDIDIASIS THERAPEUTICS MARKET SALES BY REGION
8.1 Global Candidiasis Therapeutics Sales by Region
8.1.1 Global Candidiasis Therapeutics Sales by Region
8.1.2 Global Candidiasis Therapeutics Sales Market Share by Region
8.2 Global Candidiasis Therapeutics Market Size by Region
8.2.1 Global Candidiasis Therapeutics Market Size by Region
8.2.2 Global Candidiasis Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Candidiasis Therapeutics Sales by Country
8.3.2 North America Candidiasis Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Candidiasis Therapeutics Sales by Country
8.4.2 Europe Candidiasis Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Candidiasis Therapeutics Sales by Region
8.5.2 Asia Pacific Candidiasis Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Candidiasis Therapeutics Sales by Country
8.6.2 South America Candidiasis Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Candidiasis Therapeutics Sales by Region
8.7.2 Middle East and Africa Candidiasis Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANDIDIASIS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Candidiasis Therapeutics by Region(2020-2025)
9.2 Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Candidiasis Therapeutics Production
9.4.1 North America Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Candidiasis Therapeutics Production
9.5.1 Europe Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Candidiasis Therapeutics Production (2020-2025)
9.6.1 Japan Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Candidiasis Therapeutics Production (2020-2025)
9.7.1 China Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis AG
10.1.1 Novartis AG Basic Information
10.1.2 Novartis AG Candidiasis Therapeutics Product Overview
10.1.3 Novartis AG Candidiasis Therapeutics Product Market Performance
10.1.4 Novartis AG Business Overview
10.1.5 Novartis AG SWOT Analysis
10.1.6 Novartis AG Recent Developments
10.2 Amgen
10.2.1 Amgen Basic Information
10.2.2 Amgen Candidiasis Therapeutics Product Overview
10.2.3 Amgen Candidiasis Therapeutics Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 F. Hoffmann-La Roche Ltd. Basic Information
10.3.2 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
10.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Market Performance
10.3.4 F. Hoffmann-La Roche Ltd. Business Overview
10.3.5 F. Hoffmann-La Roche Ltd. SWOT Analysis
10.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
10.4 Bayer-Algeta
10.4.1 Bayer-Algeta Basic Information
10.4.2 Bayer-Algeta Candidiasis Therapeutics Product Overview
10.4.3 Bayer-Algeta Candidiasis Therapeutics Product Market Performance
10.4.4 Bayer-Algeta Business Overview
10.4.5 Bayer-Algeta Recent Developments
10.5 Merrion Pharmaceuticals Plc.
10.5.1 Merrion Pharmaceuticals Plc. Basic Information
10.5.2 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
10.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Market Performance
10.5.4 Merrion Pharmaceuticals Plc. Business Overview
10.5.5 Merrion Pharmaceuticals Plc. Recent Developments
10.6 Ablynx
10.6.1 Ablynx Basic Information
10.6.2 Ablynx Candidiasis Therapeutics Product Overview
10.6.3 Ablynx Candidiasis Therapeutics Product Market Performance
10.6.4 Ablynx Business Overview
10.6.5 Ablynx Recent Developments
10.7 Genta Incorporated
10.7.1 Genta Incorporated Basic Information
10.7.2 Genta Incorporated Candidiasis Therapeutics Product Overview
10.7.3 Genta Incorporated Candidiasis Therapeutics Product Market Performance
10.7.4 Genta Incorporated Business Overview
10.7.5 Genta Incorporated Recent Developments
10.8 Galapagos NV
10.8.1 Galapagos NV Basic Information
10.8.2 Galapagos NV Candidiasis Therapeutics Product Overview
10.8.3 Galapagos NV Candidiasis Therapeutics Product Market Performance
10.8.4 Galapagos NV Business Overview
10.8.5 Galapagos NV Recent Developments
10.9 Catena Pharmaceuticals Inc.
10.9.1 Catena Pharmaceuticals Inc. Basic Information
10.9.2 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
10.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Market Performance
10.9.4 Catena Pharmaceuticals Inc. Business Overview
10.9.5 Catena Pharmaceuticals Inc. Recent Developments
10.10 Digna Biotech S.L.
10.10.1 Digna Biotech S.L. Basic Information
10.10.2 Digna Biotech S.L. Candidiasis Therapeutics Product Overview
10.10.3 Digna Biotech S.L. Candidiasis Therapeutics Product Market Performance
10.10.4 Digna Biotech S.L. Business Overview
10.10.5 Digna Biotech S.L. Recent Developments
10.11 Medivir AB
10.11.1 Medivir AB Basic Information
10.11.2 Medivir AB Candidiasis Therapeutics Product Overview
10.11.3 Medivir AB Candidiasis Therapeutics Product Market Performance
10.11.4 Medivir AB Business Overview
10.11.5 Medivir AB Recent Developments
10.12 Amura Holdings
10.12.1 Amura Holdings Basic Information
10.12.2 Amura Holdings Candidiasis Therapeutics Product Overview
10.12.3 Amura Holdings Candidiasis Therapeutics Product Market Performance
10.12.4 Amura Holdings Business Overview
10.12.5 Amura Holdings Recent Developments
11 CANDIDIASIS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Candidiasis Therapeutics Market Size Forecast
11.2 Global Candidiasis Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Candidiasis Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region
11.2.4 South America Candidiasis Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Candidiasis Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Candidiasis Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Candidiasis Therapeutics by Type (2026-2035)
12.1.2 Global Candidiasis Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Candidiasis Therapeutics by Type (2026-2035)
12.2 Global Candidiasis Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Candidiasis Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Candidiasis Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Candidiasis Therapeutics
1.2 Key Market Segments
1.2.1 Candidiasis Therapeutics Segment by Type
1.2.2 Candidiasis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANDIDIASIS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Candidiasis Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Candidiasis Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANDIDIASIS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Candidiasis Therapeutics Product Life Cycle
3.3 Global Candidiasis Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Candidiasis Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Candidiasis Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Candidiasis Therapeutics Market Competitive Situation and Trends
3.8.1 Candidiasis Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Candidiasis Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANDIDIASIS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Candidiasis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANDIDIASIS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Candidiasis Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Candidiasis Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Candidiasis Therapeutics Market Size by Type (2020-2025)
6.4 Global Candidiasis Therapeutics Price by Type (2020-2025)
7 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Candidiasis Therapeutics Market Sales by Application (2020-2025)
7.3 Global Candidiasis Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
8 CANDIDIASIS THERAPEUTICS MARKET SALES BY REGION
8.1 Global Candidiasis Therapeutics Sales by Region
8.1.1 Global Candidiasis Therapeutics Sales by Region
8.1.2 Global Candidiasis Therapeutics Sales Market Share by Region
8.2 Global Candidiasis Therapeutics Market Size by Region
8.2.1 Global Candidiasis Therapeutics Market Size by Region
8.2.2 Global Candidiasis Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Candidiasis Therapeutics Sales by Country
8.3.2 North America Candidiasis Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Candidiasis Therapeutics Sales by Country
8.4.2 Europe Candidiasis Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Candidiasis Therapeutics Sales by Region
8.5.2 Asia Pacific Candidiasis Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Candidiasis Therapeutics Sales by Country
8.6.2 South America Candidiasis Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Candidiasis Therapeutics Sales by Region
8.7.2 Middle East and Africa Candidiasis Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANDIDIASIS THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Candidiasis Therapeutics by Region(2020-2025)
9.2 Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Candidiasis Therapeutics Production
9.4.1 North America Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Candidiasis Therapeutics Production
9.5.1 Europe Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Candidiasis Therapeutics Production (2020-2025)
9.6.1 Japan Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Candidiasis Therapeutics Production (2020-2025)
9.7.1 China Candidiasis Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Candidiasis Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis AG
10.1.1 Novartis AG Basic Information
10.1.2 Novartis AG Candidiasis Therapeutics Product Overview
10.1.3 Novartis AG Candidiasis Therapeutics Product Market Performance
10.1.4 Novartis AG Business Overview
10.1.5 Novartis AG SWOT Analysis
10.1.6 Novartis AG Recent Developments
10.2 Amgen
10.2.1 Amgen Basic Information
10.2.2 Amgen Candidiasis Therapeutics Product Overview
10.2.3 Amgen Candidiasis Therapeutics Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 F. Hoffmann-La Roche Ltd. Basic Information
10.3.2 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
10.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Market Performance
10.3.4 F. Hoffmann-La Roche Ltd. Business Overview
10.3.5 F. Hoffmann-La Roche Ltd. SWOT Analysis
10.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
10.4 Bayer-Algeta
10.4.1 Bayer-Algeta Basic Information
10.4.2 Bayer-Algeta Candidiasis Therapeutics Product Overview
10.4.3 Bayer-Algeta Candidiasis Therapeutics Product Market Performance
10.4.4 Bayer-Algeta Business Overview
10.4.5 Bayer-Algeta Recent Developments
10.5 Merrion Pharmaceuticals Plc.
10.5.1 Merrion Pharmaceuticals Plc. Basic Information
10.5.2 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
10.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Market Performance
10.5.4 Merrion Pharmaceuticals Plc. Business Overview
10.5.5 Merrion Pharmaceuticals Plc. Recent Developments
10.6 Ablynx
10.6.1 Ablynx Basic Information
10.6.2 Ablynx Candidiasis Therapeutics Product Overview
10.6.3 Ablynx Candidiasis Therapeutics Product Market Performance
10.6.4 Ablynx Business Overview
10.6.5 Ablynx Recent Developments
10.7 Genta Incorporated
10.7.1 Genta Incorporated Basic Information
10.7.2 Genta Incorporated Candidiasis Therapeutics Product Overview
10.7.3 Genta Incorporated Candidiasis Therapeutics Product Market Performance
10.7.4 Genta Incorporated Business Overview
10.7.5 Genta Incorporated Recent Developments
10.8 Galapagos NV
10.8.1 Galapagos NV Basic Information
10.8.2 Galapagos NV Candidiasis Therapeutics Product Overview
10.8.3 Galapagos NV Candidiasis Therapeutics Product Market Performance
10.8.4 Galapagos NV Business Overview
10.8.5 Galapagos NV Recent Developments
10.9 Catena Pharmaceuticals Inc.
10.9.1 Catena Pharmaceuticals Inc. Basic Information
10.9.2 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
10.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Market Performance
10.9.4 Catena Pharmaceuticals Inc. Business Overview
10.9.5 Catena Pharmaceuticals Inc. Recent Developments
10.10 Digna Biotech S.L.
10.10.1 Digna Biotech S.L. Basic Information
10.10.2 Digna Biotech S.L. Candidiasis Therapeutics Product Overview
10.10.3 Digna Biotech S.L. Candidiasis Therapeutics Product Market Performance
10.10.4 Digna Biotech S.L. Business Overview
10.10.5 Digna Biotech S.L. Recent Developments
10.11 Medivir AB
10.11.1 Medivir AB Basic Information
10.11.2 Medivir AB Candidiasis Therapeutics Product Overview
10.11.3 Medivir AB Candidiasis Therapeutics Product Market Performance
10.11.4 Medivir AB Business Overview
10.11.5 Medivir AB Recent Developments
10.12 Amura Holdings
10.12.1 Amura Holdings Basic Information
10.12.2 Amura Holdings Candidiasis Therapeutics Product Overview
10.12.3 Amura Holdings Candidiasis Therapeutics Product Market Performance
10.12.4 Amura Holdings Business Overview
10.12.5 Amura Holdings Recent Developments
11 CANDIDIASIS THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Candidiasis Therapeutics Market Size Forecast
11.2 Global Candidiasis Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Candidiasis Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region
11.2.4 South America Candidiasis Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Candidiasis Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Candidiasis Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Candidiasis Therapeutics by Type (2026-2035)
12.1.2 Global Candidiasis Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Candidiasis Therapeutics by Type (2026-2035)
12.2 Global Candidiasis Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Candidiasis Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Candidiasis Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Candidiasis Therapeutics Market Size by Type (M USD)
Table 4. Global Candidiasis Therapeutics Market Size by Application
Table 5. Candidiasis Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Candidiasis Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Candidiasis Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Candidiasis Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Therapeutics as of 2025)
Table 11. Global Market Candidiasis Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Candidiasis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Candidiasis Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Candidiasis Therapeutics Sales by Type (K MT)
Table 27. Global Candidiasis Therapeutics Market Size by Type (M USD)
Table 28. Global Candidiasis Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Candidiasis Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Candidiasis Therapeutics Market Share by Type (2020-2025)
Table 32. Global Candidiasis Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Candidiasis Therapeutics Sales (K MT) by Application
Table 34. Global Candidiasis Therapeutics Market Size by Application
Table 35. Global Candidiasis Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Candidiasis Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Candidiasis Therapeutics Market Share by Application (2020-2025)
Table 39. Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Candidiasis Therapeutics Market Size by Region (2020-2025)
Table 44. North America Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Candidiasis Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Candidiasis Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis AG Basic Information
Table 63. Novartis AG Candidiasis Therapeutics Product Overview
Table 64. Novartis AG Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis AG Business Overview
Table 66. Novartis AG SWOT Analysis
Table 67. Novartis AG Recent Developments
Table 68. Amgen Basic Information
Table 69. Amgen Candidiasis Therapeutics Product Overview
Table 70. Amgen Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Amgen Business Overview
Table 72. Amgen SWOT Analysis
Table 73. Amgen Recent Developments
Table 74. F. Hoffmann-La Roche Ltd. Basic Information
Table 75. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
Table 76. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. F. Hoffmann-La Roche Ltd. Business Overview
Table 78. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 79. F. Hoffmann-La Roche Ltd. Recent Developments
Table 80. Bayer-Algeta Basic Information
Table 81. Bayer-Algeta Candidiasis Therapeutics Product Overview
Table 82. Bayer-Algeta Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer-Algeta Business Overview
Table 84. Bayer-Algeta Recent Developments
Table 85. Merrion Pharmaceuticals Plc. Basic Information
Table 86. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
Table 87. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Merrion Pharmaceuticals Plc. Business Overview
Table 89. Merrion Pharmaceuticals Plc. Recent Developments
Table 90. Ablynx Basic Information
Table 91. Ablynx Candidiasis Therapeutics Product Overview
Table 92. Ablynx Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Ablynx Business Overview
Table 94. Ablynx Recent Developments
Table 95. Genta Incorporated Basic Information
Table 96. Genta Incorporated Candidiasis Therapeutics Product Overview
Table 97. Genta Incorporated Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Genta Incorporated Business Overview
Table 99. Genta Incorporated Recent Developments
Table 100. Galapagos NV Basic Information
Table 101. Galapagos NV Candidiasis Therapeutics Product Overview
Table 102. Galapagos NV Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Galapagos NV Business Overview
Table 104. Galapagos NV Recent Developments
Table 105. Catena Pharmaceuticals Inc. Basic Information
Table 106. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
Table 107. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Catena Pharmaceuticals Inc. Business Overview
Table 109. Catena Pharmaceuticals Inc. Recent Developments
Table 110. Digna Biotech S.L. Basic Information
Table 111. Digna Biotech S.L. Candidiasis Therapeutics Product Overview
Table 112. Digna Biotech S.L. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Digna Biotech S.L. Business Overview
Table 114. Digna Biotech S.L. Recent Developments
Table 115. Medivir AB Basic Information
Table 116. Medivir AB Candidiasis Therapeutics Product Overview
Table 117. Medivir AB Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Medivir AB Business Overview
Table 119. Medivir AB Recent Developments
Table 120. Amura Holdings Basic Information
Table 121. Amura Holdings Candidiasis Therapeutics Product Overview
Table 122. Amura Holdings Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Amura Holdings Business Overview
Table 124. Amura Holdings Recent Developments
Table 125. Global Candidiasis Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Candidiasis Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Candidiasis Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Candidiasis Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Candidiasis Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Candidiasis Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Candidiasis Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Candidiasis Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Candidiasis Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Candidiasis Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Candidiasis Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Candidiasis Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Candidiasis Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Candidiasis Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Candidiasis Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Candidiasis Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Candidiasis Therapeutics Market Size by Type (M USD)
Table 4. Global Candidiasis Therapeutics Market Size by Application
Table 5. Candidiasis Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Candidiasis Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Candidiasis Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Candidiasis Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Therapeutics as of 2025)
Table 11. Global Market Candidiasis Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Candidiasis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Candidiasis Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Candidiasis Therapeutics Sales by Type (K MT)
Table 27. Global Candidiasis Therapeutics Market Size by Type (M USD)
Table 28. Global Candidiasis Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Candidiasis Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Candidiasis Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Candidiasis Therapeutics Market Share by Type (2020-2025)
Table 32. Global Candidiasis Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Candidiasis Therapeutics Sales (K MT) by Application
Table 34. Global Candidiasis Therapeutics Market Size by Application
Table 35. Global Candidiasis Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Candidiasis Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Candidiasis Therapeutics Market Share by Application (2020-2025)
Table 39. Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Candidiasis Therapeutics Market Size by Region (2020-2025)
Table 44. North America Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Candidiasis Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Candidiasis Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Candidiasis Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Candidiasis Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Candidiasis Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Candidiasis Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Candidiasis Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Candidiasis Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis AG Basic Information
Table 63. Novartis AG Candidiasis Therapeutics Product Overview
Table 64. Novartis AG Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis AG Business Overview
Table 66. Novartis AG SWOT Analysis
Table 67. Novartis AG Recent Developments
Table 68. Amgen Basic Information
Table 69. Amgen Candidiasis Therapeutics Product Overview
Table 70. Amgen Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Amgen Business Overview
Table 72. Amgen SWOT Analysis
Table 73. Amgen Recent Developments
Table 74. F. Hoffmann-La Roche Ltd. Basic Information
Table 75. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
Table 76. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. F. Hoffmann-La Roche Ltd. Business Overview
Table 78. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 79. F. Hoffmann-La Roche Ltd. Recent Developments
Table 80. Bayer-Algeta Basic Information
Table 81. Bayer-Algeta Candidiasis Therapeutics Product Overview
Table 82. Bayer-Algeta Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer-Algeta Business Overview
Table 84. Bayer-Algeta Recent Developments
Table 85. Merrion Pharmaceuticals Plc. Basic Information
Table 86. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
Table 87. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Merrion Pharmaceuticals Plc. Business Overview
Table 89. Merrion Pharmaceuticals Plc. Recent Developments
Table 90. Ablynx Basic Information
Table 91. Ablynx Candidiasis Therapeutics Product Overview
Table 92. Ablynx Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Ablynx Business Overview
Table 94. Ablynx Recent Developments
Table 95. Genta Incorporated Basic Information
Table 96. Genta Incorporated Candidiasis Therapeutics Product Overview
Table 97. Genta Incorporated Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Genta Incorporated Business Overview
Table 99. Genta Incorporated Recent Developments
Table 100. Galapagos NV Basic Information
Table 101. Galapagos NV Candidiasis Therapeutics Product Overview
Table 102. Galapagos NV Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Galapagos NV Business Overview
Table 104. Galapagos NV Recent Developments
Table 105. Catena Pharmaceuticals Inc. Basic Information
Table 106. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
Table 107. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Catena Pharmaceuticals Inc. Business Overview
Table 109. Catena Pharmaceuticals Inc. Recent Developments
Table 110. Digna Biotech S.L. Basic Information
Table 111. Digna Biotech S.L. Candidiasis Therapeutics Product Overview
Table 112. Digna Biotech S.L. Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Digna Biotech S.L. Business Overview
Table 114. Digna Biotech S.L. Recent Developments
Table 115. Medivir AB Basic Information
Table 116. Medivir AB Candidiasis Therapeutics Product Overview
Table 117. Medivir AB Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Medivir AB Business Overview
Table 119. Medivir AB Recent Developments
Table 120. Amura Holdings Basic Information
Table 121. Amura Holdings Candidiasis Therapeutics Product Overview
Table 122. Amura Holdings Candidiasis Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Amura Holdings Business Overview
Table 124. Amura Holdings Recent Developments
Table 125. Global Candidiasis Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Candidiasis Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Candidiasis Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Candidiasis Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Candidiasis Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Candidiasis Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Candidiasis Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Candidiasis Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Candidiasis Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Candidiasis Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Candidiasis Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Candidiasis Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Candidiasis Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Candidiasis Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Candidiasis Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Candidiasis Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Candidiasis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Candidiasis Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Candidiasis Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Candidiasis Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Candidiasis Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Candidiasis Therapeutics Product Life Cycle
Figure 13. Candidiasis Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Candidiasis Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Candidiasis Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Candidiasis Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Candidiasis Therapeutics
Figure 19. Global Candidiasis Therapeutics Market PEST Analysis
Figure 20. Global Candidiasis Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Candidiasis Therapeutics Market Share by Type
Figure 27. Sales Market Share of Candidiasis Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Candidiasis Therapeutics by Type in 2025
Figure 29. Market Share of Candidiasis Therapeutics by Type (2020-2025)
Figure 30. Market Share of Candidiasis Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Candidiasis Therapeutics Market Share by Application
Figure 33. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Candidiasis Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Candidiasis Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Candidiasis Therapeutics Market Share by Application in 2025
Figure 37. Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Candidiasis Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Candidiasis Therapeutics Market Size by Country in 2024
Figure 45. U.S. Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Candidiasis Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Candidiasis Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Candidiasis Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Candidiasis Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Candidiasis Therapeutics Market Size by Country in 2024
Figure 55. Germany Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Candidiasis Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Candidiasis Therapeutics Market Size by Region in 2024
Figure 68. China Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Candidiasis Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Candidiasis Therapeutics Market Size by Country in 2024
Figure 82. Brazil Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Candidiasis Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Candidiasis Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Candidiasis Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Candidiasis Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Candidiasis Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Candidiasis Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Candidiasis Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Candidiasis Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Candidiasis Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Candidiasis Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Candidiasis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Candidiasis Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Candidiasis Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Candidiasis Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Candidiasis Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Candidiasis Therapeutics Product Life Cycle
Figure 13. Candidiasis Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Candidiasis Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Candidiasis Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Candidiasis Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Candidiasis Therapeutics
Figure 19. Global Candidiasis Therapeutics Market PEST Analysis
Figure 20. Global Candidiasis Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Candidiasis Therapeutics Market Share by Type
Figure 27. Sales Market Share of Candidiasis Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Candidiasis Therapeutics by Type in 2025
Figure 29. Market Share of Candidiasis Therapeutics by Type (2020-2025)
Figure 30. Market Share of Candidiasis Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Candidiasis Therapeutics Market Share by Application
Figure 33. Global Candidiasis Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Candidiasis Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Candidiasis Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Candidiasis Therapeutics Market Share by Application in 2025
Figure 37. Global Candidiasis Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Candidiasis Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Candidiasis Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Candidiasis Therapeutics Market Size by Country in 2024
Figure 45. U.S. Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Candidiasis Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Candidiasis Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Candidiasis Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Candidiasis Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Candidiasis Therapeutics Market Size by Country in 2024
Figure 55. Germany Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Candidiasis Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Candidiasis Therapeutics Market Size by Region in 2024
Figure 68. China Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Candidiasis Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Candidiasis Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Candidiasis Therapeutics Market Size by Country in 2024
Figure 82. Brazil Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Candidiasis Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Candidiasis Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Candidiasis Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Candidiasis Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Candidiasis Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Candidiasis Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Candidiasis Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Candidiasis Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Candidiasis Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Candidiasis Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Candidiasis Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Candidiasis Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Candidiasis Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Candidiasis Therapeutics Market Share Forecast by Application (2026-2035)
More Publications
Global Dry Eye Disease Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
154 pages
Global Dental Carpule Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
134 pages
Global Angiography Devices Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
139 pages
Global Oregano Essential Oil Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
139 pages
Global Infertility Drugs Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
127 pages
